Efficacy of selenium supplementation for mild-to-moderate Graves' ophthalmopathy in a selenium-sufficient area (SeGOSS trial): study protocol for a phase III, multicenter, open-label, randomized, controlled intervention trial.
Chae Won ChungKyong Yeun JungEun Hye JungMin Joung LeeYoung Joo ParkJeong Kyu LeeHwa Young AhnSun Wook ChoPublished in: Trials (2023)
KCT0004040. Retrospectively registered on 5 June 2019. https://cris.nih.go.kr/cris/search/detailSearch.do/14160 .